Literature DB >> 29673469

Thyroid Hormones and Cardiovascular Function and Diseases.

Salman Razvi1, Avais Jabbar2, Alessandro Pingitore3, Sara Danzi4, Bernadette Biondi5, Irwin Klein6, Robin Peeters7, Azfar Zaman8, Giorgio Iervasi3.   

Abstract

Thyroid hormone (TH) receptors are present in the myocardium and vascular tissue, and minor alterations in TH concentration can affect cardiovascular (CV) physiology. The potential mechanisms that link CV disease with thyroid dysfunction are endothelial dysfunction, changes in blood pressure, myocardial systolic and diastolic dysfunction, and dyslipidemia. In addition, cardiac disease itself may lead to alterations in TH concentrations (notably, low triiodothyronine syndrome) that are associated with higher morbidity and mortality. Experimental data and small clinical trials have suggested a beneficial role of TH in ameliorating CV disease. The aim of this review is to provide clinicians dealing with CV conditions with an overview of the current knowledge of TH perturbations in CV disease.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute myocardial infarction; amiodarone; heart failure; thyroxine; triiodothyronine

Mesh:

Substances:

Year:  2018        PMID: 29673469     DOI: 10.1016/j.jacc.2018.02.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  63 in total

1.  Thyroid hormone: a resurgent treatment for an emergent concern.

Authors:  Mason T Breitzig; Matthew D Alleyn; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

2.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

3.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

4.  Effect of acute aerobic exercise on arterial stiffness and thyroid-stimulating hormone in subclinical hypothyroidism.

Authors:  Mitsuru Masaki; Kumi Koide; Akiko Goda; Ayako Miyazaki; Tohru Masuyama; Masahiro Koshiba
Journal:  Heart Vessels       Date:  2019-02-06       Impact factor: 2.037

Review 5.  Hypothyroidism.

Authors:  Layal Chaker; Salman Razvi; Isabela M Bensenor; Fereidoun Azizi; Elizabeth N Pearce; Robin P Peeters
Journal:  Nat Rev Dis Primers       Date:  2022-05-19       Impact factor: 52.329

Review 6.  Thyroid disorders and cardiovascular manifestations: an update.

Authors:  Stavroula A Paschou; Evanthia Bletsa; Panagiota K Stampouloglou; Vasiliki Tsigkou; Angeliki Valatsou; Katerina Stefanaki; Paraskevi Kazakou; Michael Spartalis; Eleftherios Spartalis; Evangelos Oikonomou; Gerasimos Siasos
Journal:  Endocrine       Date:  2022-01-15       Impact factor: 3.633

7.  Association of thyroid function with white coat hypertension and sustained hypertension.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Li Li; Wei Chu; Yan Wang; Xukai Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-11       Impact factor: 3.738

8.  Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The EPIPorto Study.

Authors:  João Sérgio Neves; Ricardo Fontes-Carvalho; Marta Borges-Canha; Ana Rita Leite; Sandra Martins; Ana Oliveira; João Tiago Guimarães; Davide Carvalho; Adelino Leite-Moreira; Ana Azevedo
Journal:  Eur Thyroid J       Date:  2020-07-08

9.  Impact of low triiodothyronine syndrome on long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries.

Authors:  Side Gao; Wenjian Ma; Sizhuang Huang; Xuze Lin; Mengyue Yu
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials.

Authors:  Laurien E Zijlstra; J Wouter Jukema; Rudi G J Westendorp; Robert S Du Puy; Rosalinde K E Poortvliet; Patricia M Kearney; Linda O'Keeffe; Olaf M Dekkers; Manuel R Blum; Nicolas Rodondi; Tinh-Hai Collet; Terence J Quinn; Naveed Sattar; David J Stott; Stella Trompet; Wendy P J den Elzen; Jacobijn Gussekloo; Simon P Mooijaart
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.